Completed NA INTERVENTIONAL 1-arm NCT02222038

Genetic Variants in Linear Localized Scleroderma

Investigation of the Genetic Architecture of Linear Localized Scleroderma (LLS) (Linear Morphea) by Whole Exome Sequencing. A Tailored Approach to Test the Hypothesis That LLS is a Genetic Mosaic Condition

Sponsor: University Children's Hospital, Zurich

Conditions Morphea

Interventions skin biopsy

Updated 7 times since 2017 Last updated: Nov 9, 2020 Started: Aug 31, 2014 Primary completion: Oct 31, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Morphea, this trial is completed. The trial is conducted by University Children's Hospital, Zurich and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2018 — Dec 2020 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting NA

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Children's Hospital, Zurich

Data source: University Children's Hospital, Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland